277 related articles for article (PubMed ID: 24618402)
1. GSK3β and the control of infectious bacterial diseases.
Wang H; Kumar A; Lamont RJ; Scott DA
Trends Microbiol; 2014 Apr; 22(4):208-17. PubMed ID: 24618402
[TBL] [Abstract][Full Text] [Related]
2. Regulatory role of GSK3β in the activation of NF-κB and modulation of cytokine levels in Burkholderia pseudomallei-infected PBMC isolated from streptozotocin-induced diabetic animals.
Maniam P; Nurul Aiezzah Z; Mohamed R; Embi N; Hasidah MS
Trop Biomed; 2015 Mar; 32(1):36-48. PubMed ID: 25801253
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3β inhibition improved survivability of mice infected with Burkholderia pseudomallei.
Tay TF; Maheran M; Too SL; Hasidah MS; Ismail G; Embi N
Trop Biomed; 2012 Dec; 29(4):551-67. PubMed ID: 23202600
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3β in Toll-like receptor signaling.
Ko R; Lee SY
BMB Rep; 2016 Jun; 49(6):305-10. PubMed ID: 26996345
[TBL] [Abstract][Full Text] [Related]
5. Glycogen Synthase Kinase 3β Modulates the Inflammatory Response Activated by Bacteria, Viruses, and Parasites.
Cortés-Vieyra R; Silva-García O; Gómez-García A; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM
Front Immunol; 2021; 12():675751. PubMed ID: 34017345
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
Zhang P; Katz J; Michalek SM
Mol Immunol; 2009 Feb; 46(4):677-87. PubMed ID: 18929413
[TBL] [Abstract][Full Text] [Related]
7. The complex interactions of bacterial pathogens and host defenses.
Monack DM; Hultgren SJ
Curr Opin Microbiol; 2013 Feb; 16(1):1-3. PubMed ID: 23518336
[No Abstract] [Full Text] [Related]
8. The role of JAK-3 in regulating TLR-mediated inflammatory cytokine production in innate immune cells.
Wang H; Brown J; Gao S; Liang S; Jotwani R; Zhou H; Suttles J; Scott DA; Lamont RJ
J Immunol; 2013 Aug; 191(3):1164-74. PubMed ID: 23797672
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
Coant N; Simon-Rudler M; Gustot T; Fasseu M; Gandoura S; Ragot K; Abdel-Razek W; Thabut D; Lettéron P; Ogier-Denis E; Ouziel R; Devière J; Lizard G; Tellier Z; Lebrec D; Moreau R
J Hepatol; 2011 Oct; 55(4):784-93. PubMed ID: 21334395
[TBL] [Abstract][Full Text] [Related]
10. Bacterial interference with canonical NFκB signalling.
Johannessen M; Askarian F; Sangvik M; Sollid JE
Microbiology (Reading); 2013 Oct; 159(Pt 10):2001-2013. PubMed ID: 23873783
[TBL] [Abstract][Full Text] [Related]
11. The Role of GSK3β in the Regulation of IL-10 and IL-12 Production Induced by Lipopolysaccharide in PK-15 Cells.
Wang Y; Wang Y; Xiao X; Wang L
DNA Cell Biol; 2015 Dec; 34(12):736-41. PubMed ID: 26347944
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum stress-activated glycogen synthase kinase 3β aggravates liver inflammation and hepatotoxicity in mice with acute liver failure.
Ren F; Zhou L; Zhang X; Wen T; Shi H; Xie B; Li Z; Chen D; Wang Z; Duan Z
Inflammation; 2015; 38(3):1151-65. PubMed ID: 25630719
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis.
Chen L; Ren F; Zhang H; Wen T; Piao Z; Zhou L; Zheng S; Zhang J; Chen Y; Han Y; Duan Z; Ma Y
PLoS One; 2012; 7(9):e45202. PubMed ID: 23028846
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase 3β ubiquitination by TRAF6 regulates TLR3-mediated pro-inflammatory cytokine production.
Ko R; Park JH; Ha H; Choi Y; Lee SY
Nat Commun; 2015 Apr; 6():6765. PubMed ID: 25828701
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.
Luo J
Cancer Lett; 2009 Jan; 273(2):194-200. PubMed ID: 18606491
[TBL] [Abstract][Full Text] [Related]
16. Medicinal plants with antimalarial activities mediated via glycogen synthase kinase-3 beta (GSK3β) inhibition.
Hassan WRM; Ali AH; Basir R; Embi N; Sidek HM
Trop Biomed; 2022 Sep; 39(3):384-393. PubMed ID: 36214435
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle.
Dionyssiou MG; Nowacki NB; Hashemi S; Zhao J; Kerr A; Tsushima RG; McDermott JC
J Mol Cell Cardiol; 2013 Jan; 54():35-44. PubMed ID: 23137781
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells.
Ramirez SH; Fan S; Zhang M; Papugani A; Reichenbach N; Dykstra H; Mercer AJ; Tuma RF; Persidsky Y
Am J Pathol; 2010 Feb; 176(2):881-92. PubMed ID: 20056834
[TBL] [Abstract][Full Text] [Related]
19. Bacterial manipulation of innate immunity to promote infection.
Diacovich L; Gorvel JP
Nat Rev Microbiol; 2010 Feb; 8(2):117-28. PubMed ID: 20075926
[TBL] [Abstract][Full Text] [Related]
20. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
